Study of Digestive Tolerance of Orange Juice With Fibers

NCT ID: NCT01282983

Last Updated: 2011-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dietary fiber (commonly called bulk or roughage) is the edible nondigestible component of carbohydrate and lignin naturally found in plant food; however, bacteria in the lower gut may metabolize part of it. Epidemiological studies have found that fiber intake in the population is below the suggested recommendations. The beneficial effects of the fibers in human health are recognized. The regular intake of dietary fiber has an important role in the intestinal function increasing the intestinal fecal and reducing the transit time along the intestine; collaborates with the LDL-cholesterol plasmatic reduction by increasing fecal excretion of cholesterol and bile acids, decreases postprandial glucose in healthy, diabetics and insulin resistant people, reduces the risk for developing certain cancers, promotes satiety, helps with weight loss, and exerts immunomodulatory effect. However, fiber intake may be associated with adverse effects such as flatulence, bloating, cramps, and daily consumption of orange juice to bring digestive problems associated with acidity and heartburn, epigastric burning. Then it becomes of interest to study the tolerance of a new orange juice product fortified with mixed fibers (fructooligosaccharides, resistant dextrin, polydextrose and lactulose).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Monocentric, double blind, randomized, two parallel arms controlled placebo study. 200 healthy women from 18 to 45 years old, without functional digestive disorders or diagnosed digestive disease will take part in the study. The study consists of 21 days consumption of Orange juice. The participants will be randomized in two groups: placebo (Orange juice without fiber - control) and study group (Orange juice fortified with fiber mix). In both groups, the volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digestive Alteration [PE]

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fiber

Group Type ACTIVE_COMPARATOR

Fiber

Intervention Type DIETARY_SUPPLEMENT

The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fiber

The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.

Intervention Type DIETARY_SUPPLEMENT

Placebo

The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* Tolerate the intake of orange juice routinely (at least twice/month)
* Do not use antibiotics, industrial fibers or supplements containing industrialized fibers, prebiotics and probiotics for 30 days before the start of the study
* BMI between 18,5 a 29,9 Kg/m2
* Body weight stable during the last two months
* Able to have good communication with the researcher
* Understand and agree with the rules of the study
* Making use of some contraceptive method
* Non-smokers (less than five cigarettes/day)

Exclusion Criteria

* Illiterate
* Severe alcoholics
* Allergy to orange and its juice
* Any other allergy or food intolerance
* Disease or disorder of the upper digestive tract diagnosed and treated in the last twelve months
* Inflammatory bowel diseases
* Irritable bowel syndrome
* To have diarrhea (three liquid evacuations a day)
* Pregnancy
* Lactation
* Any history of eating disorder
* Declared diseases:

* Renal insufficiency
* Hepatic Insufficiency
* Chronic Heart Failure
* Other disease which in the opinion of the investigator might be inconsistent with the study
* Be in dialysis process
* Chronic renal failure
* History or evidence of organic disease of the gastrointestinal tract
* History of cancer within five previous years (except basal cell carcinoma well treated or cervical carcinoma in situ)
* History or evidence of metabolic disturbs
* History of gastric surgery intervention (except appendectomy)
* Being under some weight loosing process or diet
* Refuse to sign the Informed Consent Term
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of São Paulo

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dan L Waitzberg, MD PhD

Role: PRINCIPAL_INVESTIGATOR

University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of São Paulo

São Paulo, São Paulo, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lilian M Horie, MsC RD

Role: CONTACT

Dan L Waitzberg, MD PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dan L Waitzberg, MD PhD

Role: primary

Lilian M Horie, RD MsC

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IKEA2010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.